AAAAAA

   
Results: 1-25 |
Results: 25
INTRACEREBELLAR TUBERCULOMA IN A PATIENT WITH AIDS - A CASE-REPORT
Authors: KOCHANEK M HARTMANN P DOLKEN G SALZBERGER B DIEHL V FATKENHEUER G
Citation: M. Kochanek et al., INTRACEREBELLAR TUBERCULOMA IN A PATIENT WITH AIDS - A CASE-REPORT, Zentralblatt fur Bakteriologie, 287(4), 1998, pp. 427-432
DOSE-RESPONSE RELATIONSHIP OF COMPLEMENTARY RADIOTHERAPY FOLLOWING 4 CYCLES OF COMBINATION CHEMOTHERAPY IN INTERMEDIATE-STAGE HODGKINS-DISEASE
Authors: LOEFFLER M DIEHL V PFREUNDSCHUH M RUHL U HASENCLEVER D NISTERSBACKES H SIEBER M TESCH H FRANKLIN J GEILEN W BARTELS H CARTONI C DOLKEN G ENZIAN J FUCHS R GASSMANN W GERHARTZ H HAGENAUKAMP U HILLER E HINKELBEIN H HINTERBERGER W KIRCHNER H KOCH P KRUGER B KURTEN H KUTZNER K LOOS U MENDE W MULLER H OERTEL W PETSCH S PFAB R PFLUGER H ROHLOFF R SAUER R SCHALK K SCHICK HD SCHOPPE W SZEPESI S TEICHMANN J WORST P FISCHER R GEORGII A HUBNER K SCHWARZE EW
Citation: M. Loeffler et al., DOSE-RESPONSE RELATIONSHIP OF COMPLEMENTARY RADIOTHERAPY FOLLOWING 4 CYCLES OF COMBINATION CHEMOTHERAPY IN INTERMEDIATE-STAGE HODGKINS-DISEASE, Journal of clinical oncology, 15(6), 1997, pp. 2275-2287
QUANTITATIVE-DETERMINATION OF T(14-18)-POSITIVE CELLS BY REAL-TIME QUANTITATIVE PCR USING A DOUBLE-LABELED FLUOROGENIC PROBE
Authors: DOLKEN L DOLKEN G
Citation: L. Dolken et G. Dolken, QUANTITATIVE-DETERMINATION OF T(14-18)-POSITIVE CELLS BY REAL-TIME QUANTITATIVE PCR USING A DOUBLE-LABELED FLUOROGENIC PROBE, Blood, 90(10), 1997, pp. 339-339
INTERIM ANALYSIS OF THE HD9 STUDY OF THE GERMAN-HODGKIN-STUDY-GROUP (GHSG) - BEACOPP IS MORE EFFECTIVE THAN COPP-ABVD IN ADVANCED-STAGE HODGKINS-DISEASE
Authors: DIEHL V LATHAN B ENGERT A FRANKLIN J RUFFER U SIEBER M WOLF J PFREUNDSCHUH M KOCH P ADLER M MULLER U SCHALK P DOLKEN G WORST P BOISSEVAIN F LOFFLER M TESCH H
Citation: V. Diehl et al., INTERIM ANALYSIS OF THE HD9 STUDY OF THE GERMAN-HODGKIN-STUDY-GROUP (GHSG) - BEACOPP IS MORE EFFECTIVE THAN COPP-ABVD IN ADVANCED-STAGE HODGKINS-DISEASE, Blood, 90(10), 1997, pp. 1512-1512
COMPARATIVE MOLECULAR AND QUANTITATIVE-ANALYSIS OF CIRCULATING T(14-18)-POSITIVE CELLS IN PATIENTS WITH FOLLICULAR LYMPHOMA IN LONG-TERM REMISSION AFTER RADIOTHERAPY
Authors: DOLKEN G HIRT C
Citation: G. Dolken et C. Hirt, COMPARATIVE MOLECULAR AND QUANTITATIVE-ANALYSIS OF CIRCULATING T(14-18)-POSITIVE CELLS IN PATIENTS WITH FOLLICULAR LYMPHOMA IN LONG-TERM REMISSION AFTER RADIOTHERAPY, Blood, 90(10), 1997, pp. 1741-1741
RAPIDLY ALTERNATING COPP PLUS ABV PLUS IMEP (CAI) IS EQUALLY EFFECTIVE AS ALTERNATING COPP PLUS ABVD (CA) FOR HODGKINS-DISEASE - FINAL RESULTS OF 2 RANDOMIZED TRIALS FOR INTERMEDIATE (HD5 PROTOCOL) AND ADVANCED (HD6 PROTOCOL) STAGES
Authors: SIEBER M RUEFFER U TESCH H LIEBERZ D PAULUS U BROSTEANU O LOEFFLER M PFREUNDSCHUH M LATHAN B DUHMKE E GEORGII A HILLER E KOCH P DOLKEN G CERNY T CARTONI C MANDELLI F DIEHL V
Citation: M. Sieber et al., RAPIDLY ALTERNATING COPP PLUS ABV PLUS IMEP (CAI) IS EQUALLY EFFECTIVE AS ALTERNATING COPP PLUS ABVD (CA) FOR HODGKINS-DISEASE - FINAL RESULTS OF 2 RANDOMIZED TRIALS FOR INTERMEDIATE (HD5 PROTOCOL) AND ADVANCED (HD6 PROTOCOL) STAGES, Blood, 90(10), 1997, pp. 2605-2605
BCL-2 J(H) REARRANGEMENTS IN CIRCULATING B-CELLS OF HEALTHY BLOOD-DONORS AND PATIENTS WITH NONMALIGNANT DISEASES/
Authors: DOLKEN G ILLERHAUS G HIRT C MERTELSMANN R
Citation: G. Dolken et al., BCL-2 J(H) REARRANGEMENTS IN CIRCULATING B-CELLS OF HEALTHY BLOOD-DONORS AND PATIENTS WITH NONMALIGNANT DISEASES/, Journal of clinical oncology, 14(4), 1996, pp. 1333-1344
INTRACEREBELLAR TUBERCULOMA IN A PATIENT WITH AIDS
Authors: KOCHANEK M HARTMANN P DOLKEN G DIEHL V FATKENHEUER G
Citation: M. Kochanek et al., INTRACEREBELLAR TUBERCULOMA IN A PATIENT WITH AIDS, AIDS, 10, 1996, pp. 82-82
HIGH-DOSE REAM CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION BY HIGH-DOSE BU CY AND SALVAGE STEM-CELL TRANSPLANTATION/
Authors: FETSCHER S WALLER CF FINKE J DOLKEN G MERTELSMANN R LANGE W
Citation: S. Fetscher et al., HIGH-DOSE REAM CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION BY HIGH-DOSE BU CY AND SALVAGE STEM-CELL TRANSPLANTATION/, Blood, 88(10), 1996, pp. 3798-3798
QUANTITATIVE-ANALYSIS OF T(14-18)-POSTIVE CELLS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR FOLLICULAR LYMPHOMA
Authors: DOLKEN G HIRT C
Citation: G. Dolken et C. Hirt, QUANTITATIVE-ANALYSIS OF T(14-18)-POSTIVE CELLS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR FOLLICULAR LYMPHOMA, Blood, 88(10), 1996, pp. 473-473
ESCALATION OF DOSE INTENSITY FOR ADVANCED-STAGE HODGKINS-DISEASE USING THE BEACOPP SCHEME - STUDIES OF THE GERMAN HODGKIN STUDY-GROUP (GHSG)
Authors: TESCH H LATHAN B RUFFER U SIEBER M ENGERT A FRANKLIN J HASENCLEVER D PFREUNDSCHUH M KOCH P ADLER M MULLER U SCHALK P DOLKEN G WORST P BOISSEVAIN F DIEHL V
Citation: H. Tesch et al., ESCALATION OF DOSE INTENSITY FOR ADVANCED-STAGE HODGKINS-DISEASE USING THE BEACOPP SCHEME - STUDIES OF THE GERMAN HODGKIN STUDY-GROUP (GHSG), Blood, 88(10), 1996, pp. 2682-2682
TRANSLOCATION T(8-13) IN A PATIENT WITH T-CELL LYMPHOMA AND FEATURES OF A MYELOPROLIFERATIVE SYNDROME
Authors: BEHRINGER D SCHAEFER HE KUNZMANN R MERTELSMANN R DOLKEN G
Citation: D. Behringer et al., TRANSLOCATION T(8-13) IN A PATIENT WITH T-CELL LYMPHOMA AND FEATURES OF A MYELOPROLIFERATIVE SYNDROME, Leukemia, 9(6), 1995, pp. 988-992
COMPARISON OF THE EFFECTS OF K-562 CELLS OF RIBOZYMES TARGETED AGAINST BCR ABL AND BCL-2 MESSENGER-RNAS/
Authors: LANGE W DASKALAKIS M SCHEID S DOLKEN G FINKE J
Citation: W. Lange et al., COMPARISON OF THE EFFECTS OF K-562 CELLS OF RIBOZYMES TARGETED AGAINST BCR ABL AND BCL-2 MESSENGER-RNAS/, Journal of cellular biochemistry, 1995, pp. 222-222
HUMAN ENDOGENOUS RETROVIRUS K10 - EXPRESSION OF GAG PROTEIN AND DETECTION OF ANTIBODIES IN PATIENTS WITH SEMINOMAS
Authors: SAUTER M SCHOMMER S KREMMER E REMBERGER K DOLKEN G LEMM I BUCK M BEST B NEUMANNHAEFELIN D MUELLERLANTZSCH N
Citation: M. Sauter et al., HUMAN ENDOGENOUS RETROVIRUS K10 - EXPRESSION OF GAG PROTEIN AND DETECTION OF ANTIBODIES IN PATIENTS WITH SEMINOMAS, Journal of virology, 69(1), 1995, pp. 414-421
DOSE-ESCALATION FOR ADVANCED-STAGE HODGKINS-DISEASE USING THE BEACOPPSCHEME - STUDIES OF THE GERMAN HODGKIN STUDY-GROUP (GHSG)
Authors: TESCH H LATHAN B HASENCLEVER D RUFFER U SIEBER M ENGERT A PFREUNDSCHUH M KOCH P ADLER M MULLER U SCHALK P DOLKEN G WORST P BOISSEVAIN F LOFFLER M DIEHL V
Citation: H. Tesch et al., DOSE-ESCALATION FOR ADVANCED-STAGE HODGKINS-DISEASE USING THE BEACOPPSCHEME - STUDIES OF THE GERMAN HODGKIN STUDY-GROUP (GHSG), Blood, 86(10), 1995, pp. 1741-1741
LONG-LIVED T(14-18)-POSITIVE B-CELLS ARE CIRCULATING IN THE PERIPHERAL-BLOOD OF HEALTHY DONORS
Authors: DOLKEN G ILLERHAUS G HIRT C
Citation: G. Dolken et al., LONG-LIVED T(14-18)-POSITIVE B-CELLS ARE CIRCULATING IN THE PERIPHERAL-BLOOD OF HEALTHY DONORS, Blood, 86(10), 1995, pp. 2407-2407
PROGNOSIS OF HIGH-DOSE CHEMOTHERAPY AUTOLOGOUS BONE-MARROW TRANSPLANTATION CANDIDATES NOT RECEIVING THIS TREATMENT AFTER FAILURE OF PRIMARYTHERAPY OF HODGKINS-DISEASE
Authors: FUCHS R LOFFLER M PFREUNDSCHUH M DOLKEN G GERHARTZ H HAGENAUKAMP U HILLER E PETSCH S PFLUGER KH RUHL U SMITH K TEICHMANN K DIEHL V
Citation: R. Fuchs et al., PROGNOSIS OF HIGH-DOSE CHEMOTHERAPY AUTOLOGOUS BONE-MARROW TRANSPLANTATION CANDIDATES NOT RECEIVING THIS TREATMENT AFTER FAILURE OF PRIMARYTHERAPY OF HODGKINS-DISEASE, Leukemia & lymphoma, 14(1-2), 1994, pp. 79-89
BCL-2 INDUCTION IS PART OF THE STRATEGY OF EPSTEIN-BARR-VIRUS
Authors: FINKE J LANGE W MERTELSMANN R DOLKEN G
Citation: J. Finke et al., BCL-2 INDUCTION IS PART OF THE STRATEGY OF EPSTEIN-BARR-VIRUS, Leukemia & lymphoma, 12(5-6), 1994, pp. 413-419
WHAT ARE SOME THERAPEUTIC APPROACHES TO A UTOIMMUNE THROMBOCYTOPENIA
Authors: DOLKEN G
Citation: G. Dolken, WHAT ARE SOME THERAPEUTIC APPROACHES TO A UTOIMMUNE THROMBOCYTOPENIA, Der Internist, 35(10), 1994, pp. 952-952
COMPARISON OF DIFFERENT RIBOZYMES FOR EFFICIENT AND SPECIFIC CLEAVAGEOF BCR ABL RELATED MESSENGER-RNAS/
Authors: LANGE W DASKALAKIS M FINKE J DOLKEN G
Citation: W. Lange et al., COMPARISON OF DIFFERENT RIBOZYMES FOR EFFICIENT AND SPECIFIC CLEAVAGEOF BCR ABL RELATED MESSENGER-RNAS/, FEBS letters, 338(2), 1994, pp. 175-178
THE SIGNIFICANCE OF SERUM LEVELS OF SOLUBLE 60 KDA RECEPTORS FOR TUMOR-NECROSIS-FACTOR IN PATIENTS WITH HODGKINS-DISEASE
Authors: GRUSS HJ DOLKEN G BRACH MA MERTELSMANN R HERRMANN F
Citation: Hj. Gruss et al., THE SIGNIFICANCE OF SERUM LEVELS OF SOLUBLE 60 KDA RECEPTORS FOR TUMOR-NECROSIS-FACTOR IN PATIENTS WITH HODGKINS-DISEASE, Leukemia, 7(9), 1993, pp. 1339-1343
SERUM LEVELS OF CIRCULATING ICAM-1 ARE INCREASED IN HODGKINS-DISEASE
Authors: GRUSS HJ DOLKEN G BRACH MA MERTELSMANN R HERRMANN F
Citation: Hj. Gruss et al., SERUM LEVELS OF CIRCULATING ICAM-1 ARE INCREASED IN HODGKINS-DISEASE, Leukemia, 7(8), 1993, pp. 1245-1249
IN-VITRO AND IN-VIVO EFFECTS OF SYNTHETIC RIBOZYMES TARGETED AGAINST BCR ABL MESSENGER-RNA/
Authors: LANGE W CANTIN EM FINKE J DOLKEN G
Citation: W. Lange et al., IN-VITRO AND IN-VIVO EFFECTS OF SYNTHETIC RIBOZYMES TARGETED AGAINST BCR ABL MESSENGER-RNA/, Leukemia, 7(11), 1993, pp. 1786-1794
EXPRESSION OF INTERLEUKIN-10 IN B-LYMPHOCYTES OF DIFFERENT ORIGIN
Authors: FINKE J TERNES P LANGE W MERTELSMANN R DOLKEN G
Citation: J. Finke et al., EXPRESSION OF INTERLEUKIN-10 IN B-LYMPHOCYTES OF DIFFERENT ORIGIN, Leukemia, 7(11), 1993, pp. 1852-1857
PERSISTENCE OF CIRCULATING T(14-18)-POSITIVE CELLS IN LONG-TERM REMISSION AFTER RADIATION-THERAPY FOR LOCALIZED-STAGE FOLLICULAR LYMPHOMA
Authors: FINKE J SLANINA J LANGE W DOLKEN G
Citation: J. Finke et al., PERSISTENCE OF CIRCULATING T(14-18)-POSITIVE CELLS IN LONG-TERM REMISSION AFTER RADIATION-THERAPY FOR LOCALIZED-STAGE FOLLICULAR LYMPHOMA, Journal of clinical oncology, 11(9), 1993, pp. 1668-1673
Risultati: 1-25 |